Overview
Tenet Healthcare Corporation, based in the United States, operates as a diversified healthcare services company primarily active within the hospital and healthcare facility sector. Founded in 1967, Tenet runs a network that includes 60 hospitals and approximately 460 outpatient centers, catering to millions of patients annually across the country. A significant aspect of their operations involves providing essential treatment services, emergency room operations, and outpatient care. Tenet also manages revenue cycle management and operational services through its subsidiary, Conifer Health Solutions, which supports healthcare systems in achieving increased efficiencies and improved financial outcomes. The company is known for focusing on expanding its ambulatory care segment through key acquisitions, aiming to broaden its reach and enhance patient care quality, reflecting its strategic growth initiatives and commitment to healthcare advancement.
AI+ Ask Fintel’s AI assistant about Tenet Healthcare Corporation.
Thinking about good questions…
Basic Stats
The share price of Tenet Healthcare Corporation as of September 5, 2025 is $196.18 / share. This is an increase of 6.43% from the prior week. The market cap (or net worth) of Tenet Healthcare Corporation as of September 5, 2025 is $17,878.86 MM.
The Factor Analysis chart (below right) shows a view of Tenet Healthcare Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 17,878.86 MM |
| EV | 32,982.78 MM |
| Shares Out. | 91.14 MM |
| Earnings Date | |
| EPS (TTM) | 16.28 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 1.50 MM |
| Short Interest | 2.39 MM |
| Short Float | 2.73 % |
| Days to Cover | 3.09 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 21.12 % |
| Volatility (1 yr) | 0.45 |
| Beta | 1.10 |
| Sharpe Ratio (1 yr) | 0.38 |
| Sortino Ratio (1 yr) | 0.62 |
| PE Ratio | 12.05 |
| Price/Book | 2.15 |
| Price/TBV | -2.09 |
| Book/Market | 0.46 |
| EBIT/EV | 0.09 |
| EBIT(3yr avg)/EV | 0.09 |
| ROA | 0.05 |
| ROE | 0.19 |
| ROIC | 0.07 |
| CROIC | -0.01 |
| OCROIC | 0.11 |
| Implied Volatility | 30.41 % |
| Put/Call OI Ratio | 0.82 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Tenet Healthcare Corporation is $199.34. The forecasts range from a low of $160.59 to a high of $249.90. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Tenet Healthcare Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-03 | Wells Fargo | Overweight | Maintains | |
| 2022-11-02 | Mizuho | Buy | Maintains | |
| 2022-11-01 | Goldman Sachs | Buy | Maintains | |
| 2022-10-27 | Raymond James | Strong Buy | Maintains | |
| 2022-10-25 | SVB Leerink | Outperform | Maintains | |
| 2022-10-25 | Citigroup | Buy | Maintains | |
| 2022-10-24 | Wells Fargo | Overweight | Maintains | |
| 2022-10-24 | Stephens & Co. | Equal-Weight | Maintains | |
| 2022-10-24 | Deutsche Bank | Buy | Maintains | |
| 2022-10-24 | Barclays | Overweight | Maintains | |
| 2022-08-24 | SVB Leerink | Outperform | Maintains | |
| 2022-08-02 | Mizuho | Buy | Maintains | |
| 2022-07-28 | UBS | Buy | Maintains | |
| 2022-07-26 | Raymond James | Strong Buy | Maintains | |
| 2022-07-26 | Citigroup | Buy | Maintains | |
| 2022-07-25 | Truist Securities | Buy | Maintains | |
| 2022-07-25 | SVB Leerink | Outperform | Maintains | |
| 2022-07-25 | RBC Capital | Outperform | Maintains | |
| 2022-07-25 | Citigroup | Buy | Maintains | |
| 2022-07-15 | SVB Leerink | Outperform | Maintains | |
| 2022-07-12 | Goldman Sachs | Buy | Maintains | |
| 2022-07-11 | Raymond James | Strong Buy | Maintains | |
| 2022-07-07 | Deutsche Bank | Buy | Maintains | |
| 2022-07-01 | Mizuho | Buy | Maintains | |
| 2022-06-17 | Loop Capital | Buy | Initiate | |
| 2022-04-25 | Wells Fargo | Overweight | Maintains | |
| 2022-04-22 | SVB Leerink | Outperform | Maintains | |
| 2022-04-22 | RBC Capital | Outperform | Maintains | |
| 2022-04-22 | Deutsche Bank | Buy | Maintains | |
| 2022-04-22 | Citigroup | Buy | Maintains | |
| 2022-04-22 | Barclays | Overweight | Maintains | |
| 2022-03-29 | Wells Fargo | Overweight | Initiate | |
| 2022-03-07 | Jefferies | Buy | Maintains | |
| 2022-03-03 | Mizuho | Buy | Maintains | |
| 2022-03-01 | Goldman Sachs | Buy | Reiterate | |
| 2022-02-10 | UBS | Neutral | Buy | Upgrade |
| 2022-02-09 | Truist Securities | Hold | Buy | Upgrade |
| 2022-02-09 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2022-02-09 | Deutsche Bank | Buy | Maintains | |
| 2022-02-09 | Credit Suisse | Outperform | Maintains | |
| 2022-02-09 | Barclays | Overweight | Maintains | |
| 2022-01-20 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2022-01-07 | SVB Leerink | Market Perform | Maintains | |
| 2022-01-05 | Truist Securities | Hold | Maintains | |
| 2021-12-21 | Barclays | Overweight | Maintains | |
| 2021-11-10 | Mizuho | Buy | Maintains | |
| 2021-11-09 | Stephens & Co. | Equal-Weight | Maintains | |
| 2021-10-25 | Citigroup | Buy | Maintains | |
| 2021-10-22 | SVB Leerink | Market Perform | Maintains | |
| 2021-10-22 | Credit Suisse | Outperform | Maintains | |
| 2021-09-27 | SVB Leerink | Market Perform | Initiate | |
| 2021-09-24 | UBS | Neutral | Initiate | |
| 2021-09-08 | Barclays | Overweight | Maintains | |
| 2021-08-12 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2021-08-09 | Mizuho | Buy | Maintains | |
| 2021-07-23 | RBC Capital | Outperform | Maintains | |
| 2021-07-23 | Credit Suisse | Outperform | Maintains | |
| 2021-07-09 | Seaport Global | Buy | Initiate | |
| 2021-04-22 | Credit Suisse | Outperform | Maintains | |
| 2021-02-11 | Credit Suisse | Outperform | Maintains | |
| 2021-01-21 | UBS | Buy | Maintains | |
| 2021-01-14 | Raymond James | Outperform | Maintains | |
| 2021-01-08 | Jefferies | Hold | Buy | Upgrade |
| 2021-01-05 | B of A Securities | Neutral | Buy | Upgrade |
| 2020-12-11 | Credit Suisse | Outperform | Maintains | |
| 2020-10-22 | Raymond James | Outperform | Maintains | |
| 2020-09-21 | JP Morgan | Neutral | Underweight | Downgrade |
| 2020-08-10 | UBS | Buy | Maintains | |
| 2020-08-05 | Deutsche Bank | Hold | Maintains | |
| 2020-06-11 | UBS | Buy | Maintains | |
| 2020-05-21 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2020-05-20 | Citigroup | Buy | Maintains | |
| 2020-05-14 | UBS | Buy | Maintains | |
| 2020-05-11 | Barclays | Equal-Weight | Maintains | |
| 2020-05-06 | Deutsche Bank | Hold | Maintains | |
| 2020-04-13 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2020-04-03 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2020-02-26 | JP Morgan | Underweight | Neutral | Upgrade |
| 2019-12-20 | JP Morgan | Underweight | Maintains | |
| 2019-12-18 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2019-12-09 | UBS | Neutral | Buy | Upgrade |
| 2019-11-20 | Raymond James | Outperform | Reiterate | |
| 2019-11-19 | Barclays | Equal-Weight | Maintains | |
| 2019-11-06 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2019-11-06 | Mizuho Securities | Buy | Maintains | |
| 2019-11-06 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2019-11-05 | Baird | Neutral | Maintains | |
| 2019-02-27 | Citigroup | Buy | Buy | Maintains |
| 2019-01-14 | Stephens & Co. | Equal-Weight | Initiate | |
| 2019-01-03 | Deutsche Bank | Hold | Initiate | |
| 2018-11-16 | UBS | Neutral | Initiate | |
| 2018-08-14 | Barclays | Equal-Weight | Initiate | |
| 2018-08-10 | JP Morgan | Underweight | Underweight | Maintains |
| 2018-07-23 | Citigroup | Buy | Buy | Maintains |
| 2018-06-29 | Jefferies | Buy | Hold | Downgrade |
| 2018-05-08 | Citigroup | Buy | Buy | Maintains |
| 2018-05-04 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-05-02 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-03-05 | JP Morgan | Underweight | Underweight | Maintains |
| 2018-03-01 | Citigroup | Buy | Buy | Maintains |
| 2018-02-28 | Wells Fargo | Market Perform | Market Perform | Maintains |
| 2018-02-28 | Raymond James | Market Perform | Outperform | Upgrade |
| 2018-02-28 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2017-12-20 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2017-12-14 | JP Morgan | Neutral | Underweight | Downgrade |
| 2017-12-12 | Citigroup | Neutral | Buy | Upgrade |
| 2017-11-21 | William Blair | Market Perform | Initiate | |
| 2017-11-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-11-02 | Credit Suisse | Neutral | Initiate | |
| 2017-10-30 | Jefferies | Buy | Maintains | |
| 2017-08-21 | Leerink Swann | Outperform | Maintains | |
| 2017-08-10 | Deutsche Bank | Buy | Maintains | |
| 2017-08-09 | Credit Suisse | Neutral | Maintains | |
| 2017-06-07 | Morgan Stanley | Equal-Weight | Initiate | |
| 2017-06-07 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2017-06-06 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2017-04-05 | Deutsche Bank | Buy | Initiate | |
| 2017-02-24 | Mizuho | Underperform | Neutral | Upgrade |
| 2017-01-04 | PiperJaffray | Neutral | Initiate | |
| 2016-11-22 | Mizuho | Neutral | Underperform | Downgrade |
| 2016-11-10 | Raymond James | Outperform | Market Perform | Downgrade |
| 2016-11-09 | Bank of America | Buy | Neutral | Downgrade |
| 2016-10-24 | Wolfe Research | Peer Perform | Initiate | |
| 2016-09-30 | Citigroup | Neutral | Maintains | |
| 2016-08-04 | Citigroup | Neutral | Maintains | |
| 2016-05-04 | Mizuho | Buy | Neutral | Downgrade |
| 2016-05-04 | Citigroup | Neutral | Maintains | |
| 2016-04-13 | Susquehanna | Neutral | Positive | Upgrade |
| 2016-03-24 | Credit Suisse | Neutral | Maintains | |
| 2016-02-24 | SunTrust Robinson Humphrey | Neutral | Maintains | |
| 2016-02-24 | Barclays | Overweight | Maintains | |
| 2016-02-23 | Credit Suisse | Neutral | Maintains | |
| 2016-01-19 | Mizuho | Neutral | Buy | Upgrade |
| 2016-01-04 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2015-12-16 | Credit Suisse | Neutral | Initiate | |
| 2015-10-22 | Mizuho | Buy | Neutral | Downgrade |
| 2015-10-08 | Barclays | Overweight | Maintains | |
| 2015-09-16 | JP Morgan | Neutral | Initiate | |
| 2015-09-10 | Barclays | Overweight | Initiate | |
| 2015-06-26 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2015-06-26 | Jefferies | Buy | Maintains | |
| 2015-06-10 | Wedbush | Outperform | Initiate | |
| 2015-03-24 | SunTrust Robinson Humphrey | Neutral | Maintains | |
| 2015-03-05 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2015-02-26 | Citigroup | Buy | Maintains | |
| 2015-02-03 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2015-02-02 | JP Morgan | Overweight | Maintains | |
| 2015-01-08 | Barclays | Overweight | Maintains | |
| 2014-11-05 | Barclays | Overweight | Maintains | |
| 2014-09-09 | Deutsche Bank | Buy | Maintains | |
| 2014-08-06 | Raymond James | Market Perform | Outperform | Upgrade |
| 2014-08-06 | JP Morgan | Overweight | Maintains | |
| 2014-08-06 | Credit Suisse | Neutral | Maintains | |
| 2014-08-06 | Citigroup | Buy | Maintains | |
| 2014-08-06 | Barclays | Overweight | Maintains | |
| 2014-08-05 | Susquehanna | Negative | Neutral | Upgrade |
| 2014-08-05 | Jefferies | Buy | Maintains | |
| 2014-06-03 | JP Morgan | Overweight | Maintains | |
| 2014-05-12 | BMO Capital | Market Perform | Maintains | |
| 2014-03-31 | Monness Crespi Hardt | Neutral | Initiate | |
| 2014-02-25 | Susquehanna | Negative | Downgrade | |
| 2014-01-08 | Raymond James | Outperform | Market Perform | Downgrade |
| 2013-11-06 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2013-10-08 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2013-10-07 | Deutsche Bank | Buy | Maintains | |
| 2013-07-11 | KeyBanc | Hold | Initiate | |
| 2013-06-06 | Deutsche Bank | Hold | Buy | Upgrade |
| 2013-04-29 | UBS | Neutral | Buy | Upgrade |
| 2013-04-10 | Deutsche Bank | Buy | Hold | Downgrade |
| 2013-03-25 | JP Morgan | Overweight | Maintains | |
| 2013-03-11 | UBS | Neutral | Maintains | |
| 2013-03-08 | Deutsche Bank | Buy | Maintains | |
| 2013-03-08 | CRT Capital | Fair Value | Buy | Upgrade |
| 2013-03-06 | Citigroup | Buy | Maintains | |
| 2013-03-04 | Jefferies | Buy | Maintains | |
| 2013-02-27 | BMO Capital | Market Perform | Maintains | |
| 2013-01-30 | Deutsche Bank | Buy | Maintains | |
| 2013-01-25 | UBS | Neutral | Maintains | |
| 2013-01-24 | Raymond James | Market Perform | Outperform | Upgrade |
| 2013-01-17 | Morgan Stanley | Equal-weight | Initiate | |
| 2013-01-11 | Bank of America | Neutral | Buy | Upgrade |
| 2013-01-03 | Imperial Capital | In-Line | Outperform | Upgrade |
| 2012-12-18 | JP Morgan | Overweight | Initiate | |
| 2012-12-17 | Deutsche Bank | Hold | Buy | Upgrade |
| 2012-11-12 | UBS | Neutral | Maintains | |
| 2012-11-09 | BMO Capital | Market Perform | Maintains | |
| 2012-11-08 | Deutsche Bank | Hold | Maintains | |
| 2012-11-08 | Barclays | Equal-Weight | Maintains | |
| 2012-10-18 | Deutsche Bank | Hold | Maintains | |
| 2012-10-12 | Barclays | Equal-Weight | Maintains | |
| 2012-10-11 | Goldman Sachs | Neutral | Maintains | |
| 2012-10-11 | Barclays | Equal-Weight | Initiate | |
| 2012-10-01 | Bank of America | Neutral | Maintains | |
| 2012-09-25 | UBS | Neutral | Maintains | |
| 2012-09-06 | Imperial Capital | In-Line | Initiate | |
| 2012-08-10 | Citigroup | Hold | Maintains | |
| 2012-06-29 | Wells Fargo | Outperform | Upgrade | |
| 2012-04-26 | Deutsche Bank | Hold | Maintains | |
| 2012-03-15 | Jefferies | Buy | Maintains | |
| 2023-02-10 | Deutsche Bank | Buy | Maintains | |
| 2023-02-10 | Truist Securities | Buy | Maintains | |
| 2023-02-10 | Mizuho | Buy | Reiterate | |
| 2023-02-10 | Stephens & Co. | Equal-Weight | Maintains | |
| 2023-02-10 | RBC Capital | Outperform | Maintains | |
| 2023-02-14 | Barclays | Overweight | Maintains | |
| 2023-02-14 | UBS | Buy | Maintains | |
| 2023-02-22 | Stephens & Co. | Equal-Weight | Maintains | |
| 2023-02-17 | Wells Fargo | Overweight | Maintains | |
| 2023-02-17 | Mizuho | Buy | Maintains | |
| 2023-04-19 | JP Morgan | Overweight | Initiate | |
| 2023-04-21 | Cantor Fitzgerald | Overweight | Initiate | |
| 2023-04-26 | Deutsche Bank | Buy | Maintains | |
| 2023-04-26 | RBC Capital | Outperformer | Maintains | |
| 2023-04-26 | Truist Securities | Buy | Maintains | |
| 2023-04-26 | Stephens & Co. | Equal-Weight | Maintains | |
| 2023-04-26 | Raymond James | Strong Buy | Maintains | |
| 2023-04-26 | Barclays | Overweight | Maintains | |
| 2023-05-16 | Mizuho | Buy | Buy | Maintains |
| 2023-06-14 | Jefferies | Buy | Reiterate | |
| 2023-06-20 | Truist Securities | Buy | Buy | Maintains |
| 2024-02-09 | Truist Securities | Buy | Buy | Maintains |
| 2023-11-09 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-03-27 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2023-08-02 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-08-02 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2023-08-01 | UBS | Buy | Buy | Maintains |
| 2023-10-31 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-10-31 | Mizuho | Buy | Buy | Maintains |
| 2023-08-14 | Goldman Sachs | Buy | Buy | Maintains |
| 2023-11-14 | Jefferies | Buy | Buy | Maintains |
| 2023-11-02 | UBS | Buy | Buy | Maintains |
| 2023-08-01 | Citigroup | Buy | Buy | Maintains |
| 2023-08-01 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-01 | RBC Capital | Outperformer | Outperform | Maintains |
| 2023-07-11 | Mizuho | Buy | Buy | Maintains |
| 2023-09-14 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2023-10-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-11-01 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2023-11-20 | Truist Securities | Buy | Buy | Reiterate |
| 2023-11-17 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-03-06 | Barclays | Overweight | Initiate | |
| 2024-02-09 | Mizuho | Buy | Buy | Maintains |
| 2024-02-09 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-02-09 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-05-30 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-05-30 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-05-30 | Baird | Outperform | Initiate | |
| 2024-05-02 | Barclays | Overweight | Overweight | Maintains |
| 2024-03-11 | Mizuho | Buy | Buy | Maintains |
| 2024-03-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-15 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-04-10 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-05-01 | UBS | Buy | Buy | Maintains |
| 2024-05-01 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-05-01 | Mizuho | Buy | Buy | Reiterate |
| 2024-05-01 | Truist Securities | Buy | Buy | Reiterate |
| 2024-05-01 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-28 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-04-12 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-07-15 | Truist Securities | Buy | Buy | Maintains |
| 2024-07-10 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-28 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-07-10 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-14 | UBS | Buy | Buy | Maintains |
| 2025-04-15 | Baird | Outperform | Neutral | Downgrade |
| 2025-02-13 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-02-13 | Barclays | Overweight | Overweight | Maintains |
| 2025-07-23 | Raymond James | Outperform | Outperform | Reiterate |
| 2025-07-23 | UBS | Buy | Buy | Maintains |
| 2025-07-23 | Guggenheim | Buy | Buy | Maintains |
| 2024-11-08 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-30 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-10-11 | Keybanc | Overweight | Initiate | |
| 2024-11-22 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2024-07-25 | Truist Securities | Buy | Buy | Reiterate |
| 2024-07-25 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2024-07-25 | Citigroup | Buy | Buy | Maintains |
| 2024-07-25 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-10-30 | Truist Securities | Buy | Buy | Reiterate |
| 2024-10-30 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-30 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-10-30 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-10-30 | UBS | Buy | Buy | Maintains |
| 2024-08-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-22 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-07-29 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-30 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-03-26 | Morgan Stanley | Overweight | Initiate | |
| 2024-10-14 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-04 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-04-30 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-30 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-04-30 | UBS | Buy | Buy | Maintains |
| 2025-01-06 | Truist Securities | Buy | Buy | Maintains |
| 2024-11-25 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2024-08-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-12-16 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2024-10-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-07-16 | Truist Securities | Buy | Buy | Maintains |
| 2025-01-07 | Keybanc | Overweight | Overweight | Maintains |
| 2025-05-29 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2025-08-14 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-04-09 | Guggenheim | Buy | Initiate | |
| 2025-05-14 | B of A Securities | Buy | Buy | Maintains |
| 2025-06-02 | Barclays | Overweight | Overweight | Maintains |
| 2025-07-25 | Baird | Neutral | Neutral | Maintains |
| 2025-05-12 | Truist Securities | Buy | Buy | Maintains |
| 2025-05-05 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-05-05 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-07-24 | Barclays | Overweight | Overweight | Maintains |
| 2025-06-09 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-07-11 | Mizuho | Outperform | Outperform | Maintains |
| 2025-07-28 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2025-08-04 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-08-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
